Загрузка...
Molecular targeting therapies for neuroblastoma: Progress and challenges
There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer‐related mortality. Neuroblastomas exhibit genetic, morphological and clinical heterogeneity, which limits the efficacy of exist...
Сохранить в:
| Опубликовано в: : | Med Res Rev |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906923/ https://ncbi.nlm.nih.gov/pubmed/33155698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/med.21750 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|